Eye Care in France

EYE CARE IN FRANCE
Euromonitor International
April 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Alcon France Sa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
Summary 1 Laboratoires Alcon France SA: Key Facts
Summary 2 Laboratoires Alcon France SA: Operational Indicators
Company Background
Production
Summary 3 Laboratoires Alcon France SA: Production Statistics 2011
Competitive Positioning
Summary 4 Laboratoires Alcon France SA: Competitive Position 2011
Cooperation Pharmaceutique Francaise Sas (cooper) in Consumer Health (france)
Strategic Direction
Key Facts
Summary 5 Cooperation Pharmaceutique Francaise SAS (Cooper): Key Facts
Summary 6 Cooperation Pharmaceutique Francaise SAS (Cooper): Operational Indicators
Company Background
Production
Summary 7 Cooperation Pharmaceutique Francaise SAS (Cooper): Production Statistics 2011
Competitive Positioning
Summary 8 Cooperation Pharmaceutique Francaise SAS (Cooper): Competitive Position 2011
Laboratoires Mcneil in Consumer Health (france)
Strategic Direction
Key Facts
Summary 9 Laboratoires McNeil: Key Facts
Summary 10 Laboratoires McNeil: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Laboratoires McNeil: Competitive Position 2011
Laboratoires Urgo SA in Consumer Health (france)
Strategic Direction
Key Facts
Summary 12 Laboratoires URGO: Key Facts
Summary 13 Laboratoires URGO: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Laboratoires URGO: Competitive Position 2011
Pierre Fabre Sa, Laboratoires in Consumer Health (france)
Strategic Direction
Key Facts
Summary 15 Laboratoires Pierre Fabre SA: Key Facts
Summary 16 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 17 Laboratoires Pierre Fabre SA: Production Statistics 2011
Competitive Positioning
Summary 18 Laboratoires Pierre Fabre SA: Competitive Position 2011
Executive Summary
Consumer Health Registers Low But Positive Value Growth in 2011
Ageing Population and Concentration in Urban Areas, Key Growth Drivers
Direct Selling and Herbal Products Behind Best-performing Operators
Pharmacies Still the Most Common Retailer for Consumer Health Products
Modest Growth Expected Over the Forecast Period
Key Trends and Developments
Hectic Lifestyles Behind Good Performances of Some Categories of OTC Drugs
Ageing Population A Major Driver for Consumer Health
Weight Management, the Most Affected by the Weak Economic Context
Transfer of Rx Drugs To OTC Market Continues To Boost Growth Potential
French Consumers Increasingly Receptive To Oral Nrt Smoking Cessation Aids
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
Summary 19 OTC - Switches 2009-2011
Definitions
Sources
Summary 20 Research Sources